Retrospective cohort study of survival length in malignant pleural effusion between 2015 and 2023
Despite recent changes in the management of MPE and improving survival trends in cancer overall, survival time following the development of MPE appears to have remained stagnant over the 8-year time period under study. This suggests that MPE should potentially be considered as a discrete clinical entity, necessitating investigation of oncological therapies specifically targeted to the pleural space.
Authors
- Nikolaos I. Kanellakis (ORCID: https://orcid.org/0000-0002-0065-2282)
- Beenish Iqbal (ORCID: https://orcid.org/0009-0008-9796-766X)
- Imogen Mechie (ORCID: https://orcid.org/0000-0002-6310-6342)
- Craig A. Mounsey (ORCID: https://orcid.org/0000-0001-5293-4786)
- Rob Hallifax (ORCID: https://orcid.org/0000-0002-9467-668X)
- Anand Sundaralingam (ORCID: https://orcid.org/0000-0001-7957-0732)
- Najib Mahboob Rahman (ORCID: https://orcid.org/0000-0003-1195-1680)
- Dinesh Addala (ORCID: https://orcid.org/0000-0002-7661-6165)
- Alguili Elsheikh (ORCID: https://orcid.org/0009-0002-9965-0240)
- Wui Mei Chew (ORCID: https://orcid.org/0000-0001-8501-8741)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- University of Oxford (GB)
- Oxford University Hospitals NHS Trust (GB)
Publication Details
- Journal
- BMJ Open Respiratory Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1136/bmjresp-2025-003609
- Citations
- 1
- Primary Topic
- Pleural and Pulmonary Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- National Institute for Health and Care Research
- Chinese Academy of Medical Sciences
- NIHR Oxford Biomedical Research Centre